Foravirumab

Foravirumab is a monoclonal antibody for the prophylaxis of rabies.[1] It is under development by Sanofi/Crucell.[2]

Foravirumab
Monoclonal antibody
TypeWhole antibody
SourceHuman
Targetrabies virus glycoprotein
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
ChEMBL
Chemical and physical data
FormulaC6400H9914N1718O1998S44
Molar mass144304.38 g·mol−1
 NY (what is this?)  (verify)

References

  1. International Nonproprietary Names for Pharmaceutical Substances (INN), World Health Organization.
  2. Khardori NM (2011). Biologic Response Modifiers in Infectious Diseases, An Issue of Infectious Disease Clinics. London: Elsevier Health Sciences. p. 158. ISBN 978-1-4557-1207-6.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.